Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.326, 2001-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Switch to lansoprazole: failure not more costly
Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. :
Access to resources
Recommend
Failure of initial antibacterial therapy costly
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. :
Graded activity no more effective, no less costly in OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 528, 2007-01 ,pp. :
RA: leflunomide more costly than methotrexate
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. :
Fewer but more costly medicines are being sold in Germany
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. :